- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 4 - Advances and Challenges in Prostate Cancer
In this segment of the panel discussion, Dr Fendrick asks the panelists if there is now a sense of optimism in reducing the mortality and quality gaps in prostate cancer treatment due to targeted screening and new molecular diagnostics, and immunotherapies.
In this segment of the panel discussion, Dr Fendrick asks the panelists if there is now a sense of optimism in reducing the mortality and quality gaps in prostate cancer treatment due to targeted screening and new molecular diagnostics, and immunotherapies. Dr Crawford notes that target screening has been around for years, but now people are listening. He does note the new molecular markers that allow clinicians to determine the aggressiveness in prostate cancer. “I think there is a lot of optimism and we are reframing this and actually listening to what people have said in the past,” said Dr Crawford.
Dr Shore replies by discussing disparities and mortalities for prostate cancer. “For prostate caner, there is virtually upwards of 100% differential in mortality through much of the Southeast of the United States and in virtually in every urban metropolitan city of this country, and it speaks to receiving inadequate care, inadequate screening, inadequate treatment, and that’s real low hanging fruit to do away with that disparity.”
Healing Wounds Through Peer Support
September 16th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
Listen
Combatting the Opioid Epidemic: Insights From the Front Lines
September 2nd 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this first episode, we speak with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
Listen
Cost Savings From an mHealth Tool for Improving Medication Adherence
October 21st 2024The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.
Read More
Methadone Associated With Lower Risk of Treatment Discontinuation in Opioid Use Disorder
October 17th 2024Amidst ambiguous international guidelines for first-line treatment of opioid use disorder, a new population-based study sheds light on the benefits of methadone vs buprenorphine/naloxone for holding off treatment discontinuation.
Read More
